Birmingham, West Midlands -- (SBWIRE) -- 12/10/2013 -- Value Penny Stocks issues special report on Magnum Hunter Resources Corp (NYSE:MHR), KB Home (NYSE:KBH), Array Biopharma Inc (NASDAQ:ARRY), Exelixis, Inc. (NASDAQ:EXEL).
Magnum Hunter Resources Corp (NYSE:MHR) ended its recent business day with the loss of -1.20% and closed at the price of $6.61 after opening at $6.70. The stock traded during its last trading session with the total volume of 3,413,908 shares, as compared to its average volume of 5.23 million shares. Magnum Hunter Resources Corporation, an independent oil and gas company, engages in the exploration, exploitation, acquisition, development, and production of crude oil, natural gas, and natural gas liquid resources in the United States and Canada.
Has MHR Found The Bottom and Ready To Move Up? Find Out Here
KB Home (NYSE:KBH) remained among the day decliners and traded with volume of 3,400,730 shares in the last session, as compared to average volume of 3.57 million shares. In comparison with 52 week range of $14.11 - $25.14, it faced lowest price of $17.47 during the last trading session whereas its day highest price was $17.99. The company’s total market capitalization is $1.46 billion, along with 83.72 million shares outstanding. KB Home operates as a homebuilding and financial services company in the United States. The company constructs and sells various homes, including attached and detached single-family residential homes, townhomes, and condominiums primarily for first-time, move-up, and active adult homebuyers.
Has KBH Found The Bottom And Ready To Gain Momentum? Find Out Here
Array Biopharma Inc (NASDAQ:ARRY) showed 3,394,690 shares in volume during the last trading session, while the average trading volume remained 1.93 million shares. The stock kicked off its trading session at $5.99 and closed at $5.23 after declining -12.54%. Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific.
Why Should Investors Buy ARRY After the Recent Fall? Just Go Here and Find Out
Exelixis, Inc. (NASDAQ:EXEL) stock traded during its last trading session with the total traded volume of 3,332,167 shares versus its average volume of 1.53 million shares. The company opened its trade at the price of $5.86 and its closing price was $5.99 after gaining 2.48% for the day. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib), an inhibitor of multiple receptor tyrosine kinases for the treatment of progressive, metastatic medullary thyroid cancer.
Why Should Investors Buy EXEL After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)